Janani Rangaswami is the chief of nephrology at the Washington DC VA Medical Center, and a professor of medicine at the George Washington University (GWU) School of Medicine. She is a clinician-researcher with expertise in cardiovascular-kidney medicine. She is the immediate past chair for the Council on the Kidney in Cardiovascular Disease of the American Heart Association (AHA), and led the AHA Scientific Statements on Cardio-Renal Syndrome (2019) and the Cardiorenal Benefits with the Newer Antidiabetic Agents in Kidney Disease (2020). She co-chaired the Cardiovascular-Kidney-Metabolic Health (CKMH) scientific advisory group for the American Heart Association which published a presidential advisory, scientific synopsis, and a novel cardiovascular disease risk prediction equation in individuals with CKM syndrome.

Dr. Rangaswami has authored several publications in cardiovascular-kidney medicine, and is the lead editor of two textbooks in this field: Textbook of Cardio-nephrology and the Textbook of Kidney Disease in the Cardiac Catheterization Laboratory. She has won several awards for teaching and leadership in her career, and co-founded the Philadelphia Agreement on Gender Equity (PAGE) in Internal Medicine, supported by the American College of Physicians. She is a frequent speaker in cardiology, nephrology, and endocrinology conferences globally.